Rationale: Unloading the diaphragm via mechanical ventilation results in rapid diaphragmatic fiber atrophy. However, it is currently unknown whether the myonuclear domain (cytoplasmic myofiber volume/myonucleus) of diaphragm myofibers is altered during mechanical ventilation. Objective: We tested the hypothesis that mechanical ventilation-induced diaphragmatic atrophy is associated with a loss of myonuclei via a caspase-3 mediated apoptotic-like mechanism resulting in a constant myonuclear domain.
INTRODUCTION

Mechanical ventilation (MV) is a clinical intervention for patients who are unable
to maintain adequate alveolar ventilation. Recent evidence reveals that controlled MV results in a swift progression of diaphragmatic atrophy and weakness (8, 18, 23, 27, 33, 35) . Importantly, it appears that this diaphragmatic atrophy and weakness contributes to difficulty in weaning patients from the ventilator (10). Unfortunately, the mechanism(s) responsible for the rapid onset of diaphragmatic atrophy and weakness are not fully understood. Therefore, delineating these mechanisms is a prerequisite for the development of therapeutic strategies to circumvent weaning difficulties.
Mechanical ventilation induced diaphragmatic atrophy and contractile dysfunction is characterized by oxidative stress and stress-related gene expression in myofibers that occurs within a matter of hours (10, 11) . In addition to myofibrillar protein loss, extracellular matrix expansion, and metabolic enzyme alterations (12, 26, 41) , prolonged disuse of skeletal muscle results in the selective loss of myonuclei (4, 16, 20, 28, 31) . Myonuclear loss may be a strategy utilized by the fiber to maintain a constant ratio of cytoplasmic myofiber volume per myonucleus (i.e., myonuclear domain) (31). The biological significance of the myonuclear domain is based on the theory that a single myonucleus can sustain necessary gene expression for limited area of cytoplasm. This notion is supported by the observation that new nuclei are incorporated into locomotor skeletal muscle fibers during growth and nuclei are lost during atrophy (4, 20, 31) . Although it is known that controlled MV decreases protein synthesis and induces proteolysis and myofiber atrophy across all fiber types (34, 35, 45) , it is currently unknown whether the myonuclear domain of diaphragm myofibers is altered during the fiber atrophy associated with MV.
Regulation of myonuclear loss in skeletal muscle could occur through extrinsic death receptor and intrinsic (sarcoplasmic reticulum and mitochondrial) mediated pathways (14) . Caspase (cysteine-dependent, aspartate-directed protease) activation results in protein cleavage and functions in both intrinsic and extrinsic pathways of apoptosis. Caspase-3, in particular, has been extensively characterized as a regulator of cellular DNA fragmentation in numerous models of skeletal muscle atrophy, including burn injury, heart failure cachexia, and hindlimb suspension (reviewed in 31). Numerous cellular mechanisms lead to caspase-3 activation, including mitochondrial dependent (cytochrome c release) and independent (e.g., Ca 2+ activation of calpain) pathways resulting in the stimulation of DNases responsible for cellular DNA fragmentation and protein degradation (14) . Oxidative stress occurs rapidly in the diaphragm during mechanical ventilation (45) and oxidant stress can promote cytochrome c release and cellular Ca 2+ overload in cells (22, 26) . This fact suggests a potential role for caspase-3 activation in the regulation of myonuclear number during the rapid atrophy that occurs in the diaphragm following prolonged MV.
Although it is clear that MV-induced diaphragm inactivity results in fiber atrophy (23, 33, 35) , it is currently unknown if prolonged MV is associated with alterations in diaphragmatic myonuclei via apoptotic mechanisms. Based on reports investigating locomotor skeletal muscle atrophy (4, 20, 28 , 31), we hypothesized that diaphragmatic inactivity during prolonged MV would result in myofiber atrophy and myonuclear loss resulting in the maintenance of a constant myonuclear domain. Moreover, we postulated that the MV-induced loss of myonuclei occurs via caspase-3 regulated apoptotic-like mechanisms. We also predicted that the initiation of myonuclear apoptosis is critically linked to MV-induced disuse atrophy. Our results support these hypotheses and establish that 12-hours of MV promotes myofiber atrophy and a caspase-3 mediated proportional decrease in myonuclear number, thereby maintaining a constant myonuclear domain.
Importantly, our data also reveal that inhibiting caspase-3 activation and myonuclear loss in the diaphragm during MV attenuates myofiber atrophy, establishing a critical link between caspase-3 activation/myonuclear apoptosis and diaphragmatic atrophy that occurs during MV.
METHODS (Word Count 495)
Experimental design. This experiment was approved by the University of Florida Animal Care and Use Committee. Adult female Sprague-Dawley rats were assigned to an acutely anesthetized control group (n = 6); 2) a 12-hour MV group (n = 6); and 3) a 12-hour MV group administered a specific caspase-3 inhibitor (n = 6; DEVD-CHO). Based upon our results from this initial study, to investigate the time course of MV-induced loss of myonuclei, we also performed a second series of experiments and randomly assigned rats to one of three experimental groups: 1) acute anesthesia control (n=6); 2) 6-hours of MV (n=6), and 3) 6-hours of MV with DEVD-CHO administration (n=6).
Acutely Anaesthetized Controls. Control animals were subjected to an acute plane of surgical anesthesia with an IP injection of sodium pentobarbital (60 mg/kg body weight).
Mechanical Ventilation. All surgical procedures were performed using aseptic techniques. MV animals were anesthetized with an IP injection of sodium pentobarbital (60 mg/kg body weight), tracheostomized, and mechanically ventilated using a volumedriven small animal ventilator (Harvard Apparatus, Cambridge, MA). An arterial catheter was inserted into the carotid artery for constant measurement of blood pressure and periodic blood sampling for analysis of arterial pH and blood gases. Upon completion of MV segments of the costal diaphragm and the plantaris muscle were then removed for analysis.
Myofiber Cross Sectional Area and Morphological Analyses. Serial sections from frozen diaphragm and plantaris samples were cut at 10 µm using a cryotome (Shandon Inc., Pittsburgh, PA) and stained for dystrophin, myosin heavy chain Type I and MHC Type IIa proteins for fiber cross sectional area analysis. Myonuclear domain (µm 3 cytoplasmic myofiber volume/myonucleus) was determined in the corresponding serial sections stained with hematoxylin and eosin (H&E).
In situ TdT-mediated dUTP nick end labeling. The nuclei with DNA strand breaks were assessed using a fluorometric TdTmediated dUTP nick end labeling (TUNEL) detection kit (1684795; Roche Applied Science, Indianapolis, IN).
Genomic DNA isolation. A section of the costal diaphragm was homogenized in 1 mL DNAzol reagent (Molecular Research Inc., Cincinnati, OH) and genomic DNA was isolated.
Ligation mediated PCR ladder assay. The detection of nucleosomal DNA ladders of apoptotic nuclei was performed using a ligation mediated PCR (LM-PCR) ladder assay kit (Maxim Biotech, Inc. San Francisco, CA) Cytosolic protein isolation. To assay the levels of caspase-3 activation in the diaphragm, a section of the ventral costal diaphragm was homogenized in Tris-HCl buffer and centrifuged for the isolation of cytosolic proteins.
Western Blot Analysis. Proteins (100 µg) from the cytosolic fraction were separated via polyacrylamide gel electrophoresis, transferred to a nitrocellulose membrane, and incubated with a primary antibodies against procaspase-3 and cleaved active caspase-3.
Membranes were then exposed to HRP conjugated secondary, exposed to chemiluminescence and developed using autoradiography film.
Statistical Design.
Comparisons between groups for each dependent variable measured were made by one-way analysis of variance (ANOVA). When significant differences were observed, a Tukey HSD (honestly significantly different) test was implemented post-hoc. Significance was established at p < 0.05.
RESULTS
Twelve-hours of MV
Systemic and biological response
Initial and final body weights of the animals did not differ (p > 0.05) between treatment groups (data not shown). Cardiovascular dynamics during MV was monitored via measurement of both heart rate and systolic blood pressure. Heart rate (365±9 beats/min) and mean blood pressure (90±4 mmHg) homeostasis were maintained during MV across all treatment groups. Blood gas homeostasis and pH (data not shown) were maintained within physiological levels during the experiment as reported previously (8, 27, 35, 45) . Since sepsis is associated with diaphragmatic contractile dysfunction, strict aseptic techniques were followed throughout the experiments (8, 27, 35, 45) . The colonic temperature of all MV animals remained constant at 37 ± 0.5 °C during the experiments.
Myofiber cross sectional area and morphological analyses of nuclear content
To characterize the response of diaphragm myofibers and myonuclei to MV, we chose a 12-hour treatment period. Twelve-hours of MV was chosen because we have previously demonstrated this duration as the early occurrence of contractile dysfunction in this model (27). Diaphragmatic myofiber cross sectional area (CSA) was determined for individual fiber types in cross sections obtained from 12-hour MV and 12-hour MV with caspase-3 inhibition via DEVD-CHO. Mechanical ventilation for 12-hours resulted in significant atrophy of Type I (17%) and Type IIa (23%) diaphragm myofibers ( Fig 1A   and 1B) . Importantly DEVD-CHO administration to animals attenuated atrophy of Type I and Type IIa diaphragm myofibers during 12-hours of MV (Fig 1B) . The plantaris muscle was also analyzed to investigate the presence of the potential confounding effects of anesthesia on myonuclei loss in locomotor skeletal muscle. However, muscle atrophy did not occur in Type I, Type IIa, or Type IIb/IIx plantaris muscle myofibers following 12-hours of MV with/without DEVD-CHO administration ( Fig 1C) .
The nuclear content of the diaphragm and plantaris muscles was determined in cross sections obtained from 12-hour MV treatment groups (Fig 2A) . Myonuclear domain (µm 3 cytoplasm / nucleus) remained constant across all fiber types in both diaphragm ( Fig 2B) and plantaris ( Fig 2C) muscle myofibers following 12-hours of MV with or without DEVD-CHO administration. Nuclei were classified as myonuclei, nonmyonuclei (including all extracellular matrix nuclei), and total muscle nuclei (myonuclei and non-myonuclei). Diaphragm muscle total nuclear content (total nuclei/mm 3 ) significantly decreased by 6% with 12hr-MV (Fig 3A) . Myonuclear content was decreased 11% (myonuclei/mm 3 ) with 12-hour MV (Fig 3B) . DEVD-CHO administration prevented the decrease in both total nuclear and myonuclear content in the diaphragm associated with prolonged MV. There were no MV or DEVD-CHO associated alterations in plantaris muscle total nuclei, myonuclei, or non-myonuclei content ( Figs 3A, B, C) .
In Situ cell death (TUNEL) and biochemical markers of apoptosis
Nuclei with DNA strand breaks were assessed using fluorometric TdTmediated dUTP nick end labeling (TUNEL; Fig 4A) . Compared to control values (0.13 ± 0.06 %), the ratio of total TUNEL positive total muscle nuclei to total muscle nuclei increased with MV (0.88 ± 0.13 %) and was attenuated by DEVD-CHO administration (0.18 ± 0.03 %). Twelve hours of MV increased the incidence of TUNEL positive myonuclei in the diaphragm (Fig 4B) whereas DEVD-CHO administration returned the incidence of TUNEL positive myonuclei baseline control values (Fig 4B) . Moreover, 12-hour MV with or without DEVD-CHO administration did not influence the incidence of TUNEL positive myonuclei in the plantaris muscle (Fig 4B) .
Further evidence of DNA fragmentation in the 12-hour MV diaphragm was investigated by ethidium-bromide agarose gel electrophoresis. Figure 5A Western blot analysis was performed to determine the expression and activity levels of caspase-3 protein ( Figure 6A ). Twelve-hours of MV did not alter the expression of procaspase-3 protein ( Figure 6B ). However, active caspase-3 significantly increased (45%) following 12-hours of MV and DEVD-CHO administration attenuated this increase ( Figure 6C ).
Six-hours of MV
Myofiber and myonuclear response
Since 12-hours of MV resulted in myofiber atrophy, loss of myonuclei, and an increase in markers of nuclear apoptosis, we investigated whether a shorter period (i.e., 6-hours) of MV altered myonuclear domain prior to the atrophy associated with 12-hours of MV. Furthermore, we determined whether inhibition of caspase-3 activity at this earlier time-point would alter the myonuclear response of the diaphragm to ventilation. We chose to investigate 6-hours of MV since we have previously established that 6-hours is 
In Situ cell death (TUNEL) and biochemical markers of apoptosis
Compared to control, DNA strand breaks assessed using fluorometric TdTmediated dUTP nick end labeling revealed an increased incidence of TUNEL positive total nuclei in diaphragm muscle from animals exposed to 6-hours of MV was not found to be significant. Compared to control values, 6-hours of MV did not alter procaspase-3 protein expression ( Figure 8B ) but was associated with a 73.0% increase (P < 0.05) in cleaved caspase-3 (caspase-3 activity; Figure 8C ). DEVD-CHO administration attenuated the increase in caspase-3 activity.
DISCUSSION
Overview of Principle Findings
We have previously shown that diaphragmatic atrophy and contractile dysfunction occurs with as little as 18-hours of controlled MV (27, 35). The current study expands upon these previous findings and reveals that atrophy of diaphragm (MHC Type I and MHC Type IIa) myofibers occurs following 12-hours of MV. Importantly, these experiments demonstrate for the first time that the myonuclear domain of atrophying diaphragm myofibers expressing MHC Type I and MHC Type IIa is maintained during MV. Moreover, the MV-induced loss of diaphragmatic myonuclei occurred in parallel with the increased number of TUNEL positive myonuclei and DNA fragmentation; this observation is consistent with the concept that apoptotic mechanisms are responsible for the loss of diaphragmatic myonuclei during prolonged MV. Lastly, our experiments also provide new and mechanistic evidence that caspase-3 activation is a requirement for MV-induced diaphragmatic myofiber atrophy and myonuclear apoptosis.
A detailed discussion of these findings is presented in the following sections.
MV-induced Alterations in Myonuclear Domain
Skeletal muscle is unique in that it is capable of modulating its size in response to alterations in functional demand. Skeletal muscle fibers are multinucleated cells and each individual myonulei is thought to control a portion of the muscle fiber; a relationship known as the myonuclear domain (5) . The ability of skeletal muscle to hypertrophy appears to be tightly coupled to the addition of myonuclei via satellite and myogenic cell fusion with existing myofibers (5) . For example, the myonuclear domain of muscle fibers is maintained during muscle fiber hypertrophy due to postnatal growth (24, 25, 43), synergistic muscle ablation (29, 38), stretch (44), or exercise (7, 9) . Muscle disuse atrophy due to a variety of experimental models results in the concurrent loss of myonuclei (3-6, 15, 17, 37 ). An important finding in the current study is MV results in the loss of diaphragm myonuclei in a manner that is proportional to the degree of Type I and Type IIa fiber atrophy, thus resulting in the maintenance of a constant myonuclear domain. This finding is consistent with previous studies investigating locomotor skeletal muscle atrophy during spaceflight induced atrophy of Type I and Type II myofibers (20).
In contrast, skeletal muscle myonuclear domain is decreased following spinal cord isolation (30) and unloading via hindlimb suspension (21). It has been theorized that differences in the response of skeletal muscle myonuclear domain size could be explained due to differences in the degree of atrophy, neural influence, muscle fiber type, or the duration of the disuse intervention (42). In this context, the diaphragm is a mixed muscle including Type I, IIa, IIb, and IIx fiber types that are not stimulated to contract during controlled MV (27). During MV, specific atrophy of Type I and Type IIa fiber types transpires in a matter of hours. In addition, Type II diaphragm muscle myofibers atrophy by approximately 30% following 18-hours of MV (35). Taken into context with the current study, these data suggest that Type II fibers in the diaphragm predominantly atrophy between 12-and 18-hours of MV. It is possible that longer periods of MV, resulting in greater total muscle myofiber atrophy could result in proportionately greater cross sectional area loss than myonuclear loss, thereby decreasing myonuclear domain.
Therefore, the maintenance of myonuclear domain during MV may, at least in part, be a factor inherent to the unique rapid nature of this model. Nonetheless, additional experiments will be required to determine the effects of longer duration MV on myonuclear domain.
MV-induced Myonuclear Apoptosis
Myonuclear apoptosis has been documented in a variety of muscle wasting conditions such as muscular dystrophy (32), denervation induced atrophy (6), aging (13, 39) , and hindlimb unloading (4, 5, 16 ) and could provide a mechanism for the maintenance of myonuclear domain during MV. Apoptosis results from the activation of endonucleases (e.g., caspase-3-mediated activation of nucleases) that cleave double-stranded DNA between nucleosomes. Detection of DNA fragments by measurement of nucleosomal DNA ladders or TUNEL are two widely used and well accepted techniques of apoptosis detection (2) . In the current experiments, the presence of nucleosomal DNA ladders and a greater number of TUNEL positive myonuclei suggests that myonuclear apoptosis occurred in the diaphragm during MV. In accordance with previous investigations, our findings may represent a modified form of "apoptosis" that results in death of myonuclei without ensuing myofiber death (4, 36) . This form of apoptosis also appears to be responsible for the elimination of myonuclei from diaphragm fibers during MV. 
Summary and Conclusions
In conclusion, this is the first study to demonstrate that myonuclear domain size is maintained during MV-induced diaphragmatic atrophy. Furthermore, the loss of myonuclei necessary for the maintenance of myonuclear domain during MV appears to be, at least in part, due to caspase-3 mediated myonuclear apoptosis. Moreover, the current data provide the first evidence that caspase-3 activation is required for diaphragmatic fiber atrophy during the first 12-hours of MV. Given that difficulty in weaning patients from MV is a significant clinical problem, it is important to develop therapeutic countermeasures to retard MV-induced diaphragmatic atrophy and weakness.
In this regard, the current investigation provides a theoretical basis for future translational clinical studies investigating caspase-3 inhibition in the diaphragm as a therapeutic countermeasure to retard MV induced diaphragm atrophy and dysfunction.
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Gallegly breaths/minute. This respiratory rate was selected to mimic the breathing frequency of adult rats at rest. Additionally, positive end-expiratory pressure of 1 cm H 2 O was used throughout the protocol. An arterial catheter was inserted into the carotid artery for constant measurement of blood pressure and periodic blood sampling for analysis of arterial pH and blood gases. Arterial blood samples (100 µL per sample) were removed during the first and last hour of MV and analyzed for arterial pCO 2 , pO 2 , and pH using a blood gas analyzer (model 1610, Instrumentation Laboratories Company, Lexington, MA). Anesthesia was maintained over the entire period of MV by continuous infusion of sodium pentobarbital (10 mg/kg body weight/hr) via a venous catheter was inserted into the jugular vein. Body temperature was maintained at 37 ± 0.5 ºC by use of a recirculating heating blanket. Additionally, heart rate and electrical activity of the heart were monitored via a lead II ECG using needle electrodes placed subcutaneously. 
